| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.08▼ | 1.08▼ | 1.08▼ | 1.09▼ | 1.12▼ |
| MA10 | 1.08▼ | 1.09▼ | 1.09▼ | 1.11▼ | 1.05▲ |
| MA20 | 1.09▼ | 1.09▼ | 1.10▼ | 1.13▼ | 0.98▲ |
| MA50 | 1.14▼ | 1.15▼ | 1.16▼ | 1.05▲ | N/A |
| MA100 | 1.17▼ | 1.15▼ | 1.13▼ | 0.99▲ | N/A |
| MA200 | 1.15▼ | 1.09▼ | 1.05▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▲ | -0.001▼ | -0.015▼ | 0.023▲ |
| RSI | 39.279▼ | 39.028▼ | 39.908▼ | 46.103▼ | 51.425▲ |
| STOCH | 21.667 | 18.333▼ | 16.212▼ | 17.005▼ | 28.280 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -88.889▼ | -80.104▼ |
| CCI | -102.973▼ | -102.275▼ | -102.825▼ | -88.965 | 29.353 |
| RSI | $IRD RSI(14) Crossed Below 50 | Set Alert |
|
Tuesday, August 05, 2025 05:43 AM
A link to the live and archived webcast may be accessed on Opus Genetics' website under the Investors section: Events .
|
|
Tuesday, August 05, 2025 05:19 AM
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ...
|
|
Tuesday, July 22, 2025 10:00 PM
RESEARCH TRIANGLE PARK, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 1.09 | 1.10 | 1.05 | 1.07 | 59,886 |
| 07/08/25 | 1.10 | 1.11 | 1.06 | 1.09 | 72,141 |
| 06/08/25 | 1.11 | 1.13 | 1.08 | 1.10 | 95,925 |
| 05/08/25 | 1.08 | 1.1362 | 1.06 | 1.11 | 76,969 |
| 04/08/25 | 1.10 | 1.10 | 1.07 | 1.08 | 59,035 |
| 01/08/25 | 1.12 | 1.129 | 1.0694 | 1.07 | 139,975 |
| 31/07/25 | 1.07 | 1.14 | 1.06 | 1.11 | 93,775 |
| 30/07/25 | 1.18 | 1.18 | 1.08 | 1.09 | 190,024 |
| 29/07/25 | 1.20 | 1.2008 | 1.14 | 1.14 | 97,898 |
| 28/07/25 | 1.21 | 1.225 | 1.18 | 1.20 | 104,726 |
|
|
||||
|
|
||||
|
|